Director John Kiely sold company shares of Amneal Pharmaceuticals, Inc. in a transaction disclosed via SEC document.
1 report, 1 independent
Updated Aug 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Director John Kiely sold company shares of Amneal Pharmaceuticals, Inc. in a transaction disclosed via SEC document.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amneal Pharmaceuticals, Inc.
American publicly traded generics and specialty pharmaceutical company
Nothing else this week.
-
John Kiely
researcher (ORCID 0000-0001-9817-0224)
Nothing else this week.